We need a robust biopharma industry, and I think everyone agrees to that, investing in rare diseases.
David McKinley: “We need a robust biopharma industry, and I think everyone agrees to that, investing in rare diseases.”
Editor's note · Context
McKinley emphasizes the importance of a strong biopharma industry for rare disease research.
Share
More from David McKinley
So I want to make sure I understand this. Let me get this straight. The Biden administration's policy to combat this overdose epidemic is to shorten sentences for fentanyl traffickers? Seriously? This is your answer?
Now, Assistant Administrator, Section 902--just in your opinion, I know that you haven't crafted the bill, but it is out there before us--Section 902 of the Clean Future Act restricts the building or expansion of American plastic…
But it appears to me the policies that have been put forth in the last ten months are doing diametrically opposite.
I will never vote for a mandate, because that is just going to make more resistance to the vaccine, and more distrust of the Federal Government.





